EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC 4.0

Administration of Calcium and Magnesium in Acute Intracerebral Hemorrhage Patients: Assessing Safety and Feasibility

Moinay Kim iD, Wonhyoung Park iD, Jun Ha Hwang iD, Jae Hyun Kim iD, Yeongu Chung iD, Si Un Lee iD, Joonho Byun iD, Jung Cheol Park iD, Jae Sung Ahn iD, Seungjoo Lee iD

Journal of Korean Medical Science · 2025

DOI: 10.3346/jkms.2025.40.e45 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Korean Medical Science, 2025. Verfasst von Moinay Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Magnesium, Calcium, Cerebral Hemorrhage. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCIRD CDC HHS, Asan Institute for Life Sciences, Asan Medical Center, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Serum calcium and magnesium levels are a key factor of the coagulation cascade and may potentially contribute to the pathophysiology of intracerebral hemorrhage (ICH) expansion. The aim of this study was to attain and sustain target levels of serum calcium and magnesium for three days following admission. METHODS: A single-blind, prospective, multicenter randomized study was conducted from 2019 to 2022 years, enrolling acute ICH patients aged 18-80 years, with radiological diagnosis and without surgical intervention. Participants were randomly assigned in a 1:1 ratio to either the study group or the control group. In the study group, the target serum levels of calcium (9-10.2 mg/dL) and magnesium (2-3 mg/dL) were actively achieved and maintained for a duration of 3 days following admission. The primary outcome was the expansion of ICH volume within the first 3 days between the study group and the control groups. RESULTS: After implementing inclusion/exclusion criteria, 105 of 354 patients remained in the study. There were no significant differences in ICH volume on hospital days 2 and 3 between the groups. Admission factors including Glasgow coma scale score, hemoglobin level, ICH volume, and spot sign showed significant correlations in multivariate analysis. On the third day of hospitalization, admission serum magnesium levels showed a significant correlation with ICH expansion, whereas calcium levels did not. CONCLUSION: Admission serum magnesium levels were found to correlate with hematoma expansion in patients with acute ICH. While magnesium itself may not be a direct therapeutic target, it could serve as a valuable indicator for identifying potential therapeutic strategies aimed at preventing ICH volume increase. TRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0004427.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MagnesiumCalciumCerebral HemorrhageHumansMaleMiddle AgedFemaleAgedAdultProspective StudiesAged, 80 and overSingle-Blind MethodAdolescentGlasgow Coma ScaleYoung AdultAcute Disease

Stichwörter der Autor:innen

CalciumCerebrovascular HematomaIntracerebral HemorrhageMagnesiumStroke

Substanzen

MagnesiumCalcium

Autor:innen und Institutionen

  • Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Neurosurgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea.
  • Department of Neurosurgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. changhill@gmail.com.

ORCID-Profile: Moinay Kim, Wonhyoung Park, Jun Ha Hwang, Jae Hyun Kim, Yeongu Chung, Si Un Lee, Joonho Byun, Jung Cheol Park, Jae Sung Ahn, Seungjoo Lee

Förderung

  • NCIRD CDC HHS
  • Asan Institute for Life Sciences, Asan Medical Center
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Kim, M., Park, W., Hwang, J. H., Kim, J. H., Chung, Y., Lee, S. U., Byun, J., Park, J. C., Ahn, J. S., & Lee, S. (2025). Administration of Calcium and Magnesium in Acute Intracerebral Hemorrhage Patients: Assessing Safety and Feasibility. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2025.40.e45

Vancouver

Kim M, Park W, Hwang JH, Kim JH, Chung Y, Lee SU, et al. Administration of Calcium and Magnesium in Acute Intracerebral Hemorrhage Patients: Assessing Safety and Feasibility. Journal of Korean Medical Science. 2025. doi:10.3346/jkms.2025.40.e45

BibTeX
@article{Kim2025,
  author = {Kim, Moinay and Park, Wonhyoung and Hwang, Jun Ha and Kim, Jae Hyun and Chung, Yeongu and Lee, Si Un and Byun, Joonho and Park, Jung Cheol and Ahn, Jae Sung and Lee, Seungjoo},
  title = {Administration of Calcium and Magnesium in Acute Intracerebral Hemorrhage Patients: Assessing Safety and Feasibility},
  journal = {Journal of Korean Medical Science},
  year = {2025},
  doi = {10.3346/jkms.2025.40.e45}
}
Kostenlos starten →